{
    "clinical_study": {
        "@rank": "110838", 
        "arm_group": [
            {
                "arm_group_label": "Rowachol", 
                "arm_group_type": "Experimental", 
                "description": "Rowachol treatment with 200mg PO tid, on postoperative 1 days to 3 months"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo treatment with 200mg PO tid, on postoperative 1 days to 3 months"
            }
        ], 
        "brief_summary": {
            "textblock": "Postcholecystectomy syndrome (PCS) includes a heterogeneous group of diseases, usually\n      manifested by the presence of abdominal symptoms following gallbladder removal. The\n      pathogenesis of PCS has not been identified; therefore there is no consensus of medical\n      treatment on PCS. The Action of Rowachol are to inhibit hepatic 3-hydroxy-3-methylglutaric\n      acid(HMG)-coenzyme A(CoA) reductase, to inhibits cholesterol nucleation in bile from\n      patients with cholesterol gallstones, and to promote biliary lipid secretion.\n\n      The purpose of this study is to determine whether Rowachol is useful in the prevention of\n      PCS and symptoms change after laparoscopic cholecystectomy"
        }, 
        "brief_title": "Effect of Rowachol on Prevention of Postcholecystectomy Syndrome", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Postcholecystectomy Syndrome", 
        "condition_browse": {
            "mesh_term": "Postcholecystectomy Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with pathologic diseases scheduled for laparoscopic cholecystectomy\n\n        Exclusion Criteria:\n\n          -  Current immunosuppressive therapy\n\n          -  Chemotherapy within 4 weeks before operation\n\n          -  Radiotherapy completed longer than 4 weeks before operation\n\n          -  Inability to follow the instructions given by the investigator\n\n          -  Severe psychiatric or neurologic diseases\n\n          -  Drug- and/or alcohol-abuse according to local standards\n\n          -  Participation in another intervention-trial with interference of a primary  or\n             secondary endpoint of this study\n\n          -  Lack of compliance\n\n          -  Lack of informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "84 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "138", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01765465", 
            "org_study_id": "S-2012-E0816-00001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Rowachol", 
                "intervention_name": "Rowachol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "postcholecystectomy syndrome", 
            "laparoscopic cholecystectomy", 
            "Rowachol"
        ], 
        "lastchanged_date": "April 2, 2014", 
        "location": [
            {
                "contact": {
                    "email": "cardioman76@gmail.com", 
                    "last_name": "In Woong Han, M.D.", 
                    "phone": "82-31-961-7567"
                }, 
                "contact_backup": {
                    "email": "mgo59@hanmail.net", 
                    "last_name": "Min Gu Oh, M.D., PhD.", 
                    "phone": "82-31-961-7261"
                }, 
                "facility": {
                    "address": {
                        "city": "Goyang", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi", 
                        "zip": "410-773"
                    }, 
                    "name": "DongGuk University Ilsan Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "In Woong Han, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Min Gu Oh, M.D., PhD.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "selee@cau.ac.kr", 
                    "last_name": "Seung Eun Lee, M.D., PhD.", 
                    "phone": "82-10-8912-3073"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "156-755"
                    }, 
                    "name": "Chung-Ang University Hospital"
                }, 
                "investigator": {
                    "last_name": "Seung Eun Lee, M.D., PhD.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Rowachol on Prevention of Postcholecystectomy Syndrome After Laparoscopic Cholecystectomy", 
        "overall_contact": {
            "email": "cardioman76@gmail.com", 
            "last_name": "In Woong Han, M.D.", 
            "phone": "82-31-961-7567"
        }, 
        "overall_official": {
            "affiliation": "DongGuk University College of Medicine", 
            "last_name": "In Woong Han, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry for Health, Welfare and Family Affairs", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Right upper quadrant(RUQ) pain by European Organization for Research and Treatment of Cancer(EORTC) quality of life questionnaire(QLQ) C-30 No. 9, 19 at baseline and postoperative 3 months after.\nThe difference of Pain score from 3months to baseline will be calculated by EORTC QLQ C-30 manual.", 
            "measure": "Right upper quadrant(RUQ) pain score", 
            "safety_issue": "No", 
            "time_frame": "baseline and postoperative 3 months after"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01765465"
        }, 
        "responsible_party": {
            "investigator_affiliation": "DongGuk University", 
            "investigator_full_name": "In Woong Han", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "3 months minus baseline", 
            "measure": "Changing pattern of liver function test", 
            "safety_issue": "No", 
            "time_frame": "baseline and postoperative 3 months after"
        }, 
        "source": "DongGuk University", 
        "sponsors": {
            "collaborator": {
                "agency": "Pharmbio Korea Co., Ltd.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "DongGuk University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}